Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Curevac N.V. buy Gilbert

Start price
€81.89
13.01.21 / 80%
Target price
€101.00
Performance (%)
23.31%
End price
€100.98
08.02.21
Summary
This prediction ended on 08.02.21 with a price of €100.98. The BUY prediction by Gilbert finished with a performance of 23.31%. Gilbert has 80% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Curevac N.V. 5.450% 5.450% - -
iShares Core DAX® 4.094% 3.543% 17.404% 20.326%
iShares Nasdaq 100 1.424% 0.512% 39.212% 55.365%
iShares Nikkei 225® -1.572% -4.633% 15.731% 2.146%
iShares S&P 500 1.822% 0.963% 30.396% 45.950%

According to Gilbert what are the pros and cons of Curevac N.V. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Top 10 in its market
Cons

Comments by Gilbert for this prediction

In the thread Curevac N.V. diskutieren
Prediction Buy
Perf. (%) 23.31%
Target price 100.000
Change
Ends at

Buy mit Kursziel 100,0

Prediction Buy
Perf. (%) 23.31%
Target price 90.000
Change
Ends at

Kursziel geändert auf 90,0

Prediction Buy
Perf. (%) 23.31%
Target price 93.000
Change
Ends at

Kursziel geändert auf 93,0

Prediction Buy
Perf. (%) 23.31%
Target price 98.000
Change
Ends at

Kursziel geändert auf 98,0

Prediction Buy
Perf. (%) 23.31%
Target price 101.000
Change
Ends at

Kursziel geändert auf 101,0

In the thread Trading Curevac N.v.
Prediction Buy
Perf. (%) 23.31%
Target price 101.000
Change
Ends at

Buy beendet

Stopped prediction by Gilbert for Curevac N.V.

buy
Curevac N.V.

Start price
Target price
Perf. (%)
€100.20
29.04.21
-
29.04.25
-96.69%
12.01.24

Could be worthwhile Investment >10% per year
Top 10 in its market
buy
Curevac N.V.

Start price
Target price
Perf. (%)
€105.96
08.02.21
-
08.02.22
2.02%
28.04.21

Could be worthwhile Investment >10% per year
Top 10 in its market